Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A major UK research study into the long-term health impacts of COVID-19 on hospitalised patients has been launched.

The Post-Hospitalisation COVID-19 Study (PHOSP-COVID) study has been awarded £8.4million jointly by UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR). This study is one of a number of COVID-19 studies that have been given urgent public health research status by the Department of Health and Social Care.

Professor Ling-Pei Ho (MRC Weatherall Institute of Molecular Medicine), Professor John Geddes (Department of Psychiatry) and Professor Stefan Neubauer (Radcliffe Department of Medicine) are part of the national consortium group of leading researchers and clinicians from across the UK to assess the impact of COVID-19 on patients’ health and their recovery.

The full story is available on the MRC Weatherall Institute of Molecular Medicine website and also the Department of Psychiatry website.